hiPSC-RPE 4 (AMD 4) NAM
Homo sapiens
source_name
hiPSC-RPE 4 treated with Nictinamide for 3 weeks
gender
male
age
75
disease status
Age related Macular degeneration (AMD)
treatment
Nicotinamide
tissue of origin
RPE